FR2051523A1 - - Google Patents

Info

Publication number
FR2051523A1
FR2051523A1 FR7017382A FR7017382A FR2051523A1 FR 2051523 A1 FR2051523 A1 FR 2051523A1 FR 7017382 A FR7017382 A FR 7017382A FR 7017382 A FR7017382 A FR 7017382A FR 2051523 A1 FR2051523 A1 FR 2051523A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7017382A
Other versions
FR2051523B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parke Davis and Co LLC
Original Assignee
Parke Davis and Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis and Co LLC filed Critical Parke Davis and Co LLC
Publication of FR2051523A1 publication Critical patent/FR2051523A1/fr
Application granted granted Critical
Publication of FR2051523B1 publication Critical patent/FR2051523B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18—One oxygen or sulfur atom
    • C07D231/20—One oxygen atom attached in position 3 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C07D231/40—Acylated on said nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7017382A 1969-05-14 1970-05-13 Expired FR2051523B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82468769A 1969-05-14 1969-05-14
US2401270A 1970-03-30 1970-03-30

Publications (2)

Publication Number Publication Date
FR2051523A1 true FR2051523A1 (fr) 1971-04-09
FR2051523B1 FR2051523B1 (fr) 1974-04-12

Family

ID=26697913

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7017382A Expired FR2051523B1 (fr) 1969-05-14 1970-05-13

Country Status (9)

Country Link
US (2) US3558605A (fr)
AT (4) AT298500B (fr)
BE (1) BE750367A (fr)
CH (4) CH522664A (fr)
DE (1) DE2023453C3 (fr)
FR (1) FR2051523B1 (fr)
GB (2) GB1268607A (fr)
NL (1) NL148320B (fr)
SE (1) SE380016B (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2184392A1 (en) * 1972-05-15 1973-12-28 Abbott Lab 1,3-dimethyl-5-methylamino-8-phenylpyrazolo (4,3-e)(1,4)diazepine-ant
FR2210403A1 (fr) * 1972-12-15 1974-07-12 Parke Davis & Co
FR2229409A1 (fr) * 1973-05-16 1974-12-13 Parke Davis & Co

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3879535A (en) * 1973-02-20 1975-04-22 Parke Davis & Co Anesthetic compositions and methods of use
DE2747531A1 (de) * 1977-10-22 1979-04-26 Basf Ag Substituierte 3-aminopyrazole
DE2932835A1 (de) * 1979-08-14 1981-03-26 Hoechst Ag, 65929 Frankfurt Neue 4-aryl-5,6,7,8-tetrahydropyrazolo(3,4-b)diazepin-1h,4h-5,7-dione und verfahren zu ihrer darstellung
ES513399A0 (es) * 1981-06-26 1983-03-01 Warner Lambert Co Un procedimiento para preparar derivados de dialcohilpirazol
NZ208555A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (3-amino-1h-pyrazol-4-yl)-arylmethanone derivatives
US4900836A (en) * 1983-06-23 1990-02-13 American Cyanamid Company (3-amino-1H-pyrazol-4-yl) (aryl)methanones
US4980472A (en) * 1983-06-23 1990-12-25 American Cyanamid Company Method of making (3-amino-1H-pyrazol-4-yl) (aryl)methanones
DE4314851A1 (de) * 1993-05-05 1994-11-10 Huels Chemische Werke Ag Verfahren zur Herstellung von 3-Amino-5-methylpyrazol
US6316466B1 (en) * 1998-05-05 2001-11-13 Syntex (U.S.A.) Llc Pyrazole derivatives P-38 MAP kinase inhibitors

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2184392A1 (en) * 1972-05-15 1973-12-28 Abbott Lab 1,3-dimethyl-5-methylamino-8-phenylpyrazolo (4,3-e)(1,4)diazepine-ant
FR2210403A1 (fr) * 1972-12-15 1974-07-12 Parke Davis & Co
FR2229409A1 (fr) * 1973-05-16 1974-12-13 Parke Davis & Co

Also Published As

Publication number Publication date
DE2023453A1 (de) 1970-11-19
CH510040A (fr) 1971-07-15
US3660425A (en) 1972-05-02
FR2051523B1 (fr) 1974-04-12
AT298500B (de) 1972-05-10
CH522665A (de) 1972-05-15
AT299961B (de) 1972-07-10
US3558605A (en) 1971-01-26
CH522663A (fr) 1972-05-15
DE2023453B2 (de) 1974-09-05
NL7006933A (fr) 1970-11-17
GB1268608A (en) 1972-03-29
BE750367A (fr) 1970-10-16
AT297709B (de) 1972-04-10
AT297719B (de) 1972-03-15
DE2023453C3 (de) 1975-04-10
NL148320B (nl) 1976-01-15
SE380016B (fr) 1975-10-27
CH522664A (fr) 1972-05-15
GB1268607A (en) 1972-03-29

Similar Documents

Publication Publication Date Title
AU465413B2 (fr)
AU429630B2 (fr)
FR2051523B1 (fr)
AU450150B2 (fr)
CS148407B1 (fr)
CS149934B2 (fr)
CS151567B2 (fr)
AU470301B1 (fr)
AU427401B2 (fr)
AU410358B2 (fr)
AU428074B2 (fr)
AU425297B2 (fr)
AU470661B1 (fr)
AU428131B2 (fr)
AU428129B2 (fr)
AU417208B2 (fr)
AU414607B2 (fr)
AU5133369A (fr)
AU4923469A (fr)
AU5079269A (fr)
BE739781A (fr)
BE743890A (fr)
AU5066368A (fr)
AU5006968A (fr)
AU4982068A (fr)